Francisella tularensis
is a Gram-negative bacterium that causes a fatal human disease known as tularemia. The Centers for Disease Control have classified
F. tularensis
as Category A Tier-1 Select Agent. The virulence mechanisms of
Francisella
are not entirely understood.
Francisella
possesses very few transcription regulators, and most of these regulate the expression of genes involved in intracellular survival and virulence. The
F. tularensis
genome sequence analysis reveals an AraC (
FTL_
0689) transcriptional regulator homologous to the AraC/XylS family of transcriptional regulators. In Gram-negative bacteria, AraC activates genes required for L-arabinose utilization and catabolism. The role of the
FTL_
0689 regulator in
F. tularensis
is not known. In this study, we characterized the role of
FTL_
0689 in gene regulation of
F. tularensis
and investigated its contribution to intracellular survival and virulence. The results demonstrate that
FTL_0689
in
Francisella
is not required for L-arabinose utilization. Instead,
FTL_
0689 specifically regulates the expression of the oxidative and global stress response, virulence, metabolism, and other key pathways genes required by
Francisella
when exposed to oxidative stress. The
FTL_0689
mutant is attenuated for intramacrophage growth and virulence in mice. Based on the deletion mutant phenotype,
FTL_0689
was termed
osrR
(
o
xidative
s
tress
r
esponse
r
egulator). Altogether, this study elucidates the role of the
osrR
transcriptional regulator in tularemia pathogenesis.
IMPORTANCE:
The virulence mechanisms of category A select agent
Francisella tularensis
, the causative agent of a fatal human disease known as tularemia, remain largely undefined. The present study investigated the role of a transcriptional regulator and its overall contribution to the oxidative stress resistance of
F. tularensis
. The results provide an insight into a novel gene regulatory mechanism, especially when
Francisella
is exposed to oxidative stress conditions. Understanding such
Francisella
- specific regulatory mechanisms will identify potential targets for developing effective therapies and vaccines to prevent tularemia.